Have a personal or library account? Click to login
Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study Cover

Longitudinal monitoring of Apparent Diffusion Coefficient (ADC) in patients with prostate cancer undergoing MR-guided radiotherapy on an MR-Linac at 1.5 T: a prospective feasibility study

Radiology and Oncology
Volume 57 (2023): Issue 2 (June 2023)
By: Haidara Almansour,  Fritz Schick,  Marcel Nachbar,  Saif Afat,  Victor Fritz,  Daniela Thorwarth,  Daniel Zips,  Felix Bertram,  Arndt-Christian Müller,  Konstantin Nikolaou,  Ahmed E Othman and  Daniel Wegener  
Open Access
|Jun 2023

Authors

Haidara Almansour

Department of Diagnostic and Interventional Radiology, Eberhard-Karls University, Tuebingen, Germany

Fritz Schick

Section for Experimental Radiology, Department of Radiology, Eberhard-Karls University, Tuebingen, Germany

Marcel Nachbar

Department of Radiation Oncology, Charité University Medicine Berlin, Berlin, Germany
Section for Biomedical Physics, Department of Radiation Oncology, Eberhard-Karls University, Tuebingen, Germany

Saif Afat

Department of Diagnostic and Interventional Radiology, Eberhard-Karls University, Tuebingen, Germany

Victor Fritz

Section for Experimental Radiology, Department of Radiology, Eberhard-Karls University, Tuebingen, Germany

Daniela Thorwarth

Section for Biomedical Physics, Department of Radiation Oncology, Eberhard-Karls University, Tuebingen, Germany
German Cancer Consortium (DKTK), Partner Site Tuebingen and German Cancer Research Center (DKFZ), Heidelberg, Germany

Daniel Zips

Department of Radiation Oncology, Charité University Medicine Berlin, Berlin, Germany
German Cancer Consortium (DKTK), Partner Site Tuebingen and German Cancer Research Center (DKFZ), Heidelberg, Germany
Department of Radiation Oncology, Eberhard-Karls University, Tuebingen, Germany

Felix Bertram

Department of Radiation Oncology, Eberhard-Karls University, Tuebingen, Germany

Arndt-Christian Müller

Department of Radiation Oncology, Eberhard-Karls University, Tuebingen, Germany
Department of Radiation Oncology, RKH Klinikum Ludwigsburg, Ludwigsburg, Germany

Konstantin Nikolaou

Department of Diagnostic and Interventional Radiology, Eberhard-Karls University, Tuebingen, Germany
Cluster of Excellence iFIT (EXC 2180) “Image Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany

Ahmed E Othman

ahmed.e.othman@googlemail.com

Department of Diagnostic and Interventional Radiology, Eberhard-Karls University, Tuebingen, Germany
Department of Neuroradiology, University Medical Center Mainz, Mainz, Germany

Daniel Wegener

Department of Radiation Oncology, Eberhard-Karls University, Tuebingen, Germany
DOI: https://doi.org/10.2478/raon-2023-0020 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 184 - 190
Submitted on: Jan 20, 2023
Accepted on: Mar 30, 2023
Published on: Jun 21, 2023
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
prostate carcinoma,
MRI,
adaptive radiotherapy,
image guidance,
MR-Linac,
ADC
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2023 Haidara Almansour, Fritz Schick, Marcel Nachbar, Saif Afat, Victor Fritz, Daniela Thorwarth, Daniel Zips, Felix Bertram, Arndt-Christian Müller, Konstantin Nikolaou, Ahmed E Othman, Daniel Wegener, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous articleVolume 57 (2023): Issue 2 (June 2023)Next article